AKS-130(Akston Biosciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAKS-130(Akston Biosciences)
Drug Alias NameAKS-130
ClassificationBiologics > Protein drugs
Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants
TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkston Biosciences Corp
China Registration ClassN/A

Develop Information

Active CompaniesAkston Biosciences Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A